HIV Infection (ARV CCR5 Antagonists) (RXNORM)

{
  "description" : "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), or SBD (semantic brand drug). GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set. This value set does not include oral administration concepts, only concepts for medications administered specifically for overdose (injection, nasal).",
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 10
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2022-01-18T01:02:45-05:00",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "CSTE Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values contains codes for prescribable medications for HIV),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: ARV CCR5 Antagonists),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)",
  "name" : "HIVInfectionARVCCR5AntagonistsRXNORM",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857911",
      "display" : "maraviroc 25 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857913",
      "display" : "maraviroc 25 MG Oral Tablet [Selzentry]",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857915",
      "display" : "maraviroc 75 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857917",
      "display" : "maraviroc 75 MG Oral Tablet [Selzentry]",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857921",
      "display" : "maraviroc 20 MG/ML Oral Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1857925",
      "display" : "maraviroc 20 MG/ML Oral Solution [Selzentry]",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "728223",
      "display" : "maraviroc 150 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "728225",
      "display" : "maraviroc 300 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "729201",
      "display" : "maraviroc 150 MG Oral Tablet [Selzentry]",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "729203",
      "display" : "maraviroc 300 MG Oral Tablet [Selzentry]",
      "version" : "05062024"
    } ],
    "total" : 10,
    "identifier" : "urn:uuid:41dbca05-c886-41ac-bbd3-28b2482efaf3",
    "timestamp" : "2024-06-14T11:54:59-04:00"
  },
  "title" : "HIV Infection (ARV CCR5 Antagonists) (RXNORM)",
  "extension" : [ {
    "valueString" : "CSTE Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueString" : "HIV,Trigger",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord"
  }, {
    "valueDate" : "2024-06-03",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2022-01-18",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "2.16.840.1.113762.1.4.1146.1599",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1599",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1146.1599"
  } ],
  "version" : "20220118"
}